Please use this identifier to cite or link to this item: https://doi.org/10.1155/2016/6120143
DC FieldValue
dc.titleQuality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
dc.contributor.authorAhmed, S
dc.contributor.authorDe Souza, N.N
dc.contributor.authorQiao, W
dc.contributor.authorKasai, M
dc.contributor.authorKeem, L.J
dc.contributor.authorShelat, V.G
dc.date.accessioned2020-10-23T08:04:38Z
dc.date.available2020-10-23T08:04:38Z
dc.date.issued2016
dc.identifier.citationAhmed, S, De Souza, N.N, Qiao, W, Kasai, M, Keem, L.J, Shelat, V.G (2016). Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization. HPB Surgery 2016 : 6120143. ScholarBank@NUS Repository. https://doi.org/10.1155/2016/6120143
dc.identifier.issn0894-8569
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/179619
dc.description.abstractHepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers worldwide. Majority of patients with HCC are diagnosed in the advanced stages of disease and hence they are only suitable for palliative therapy. TACE (transarterial chemoembolization) is the most commonly used treatment for unresectable HCC. It is however unclear if TACE improves the quality of life (QoL) in patients with HCC. The aim of this review is to evaluate the impact of TACE on QoL of HCC patients. © 2016 Saleem Ahmed et al.
dc.publisherHindawi Limited
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.typeArticle
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.1155/2016/6120143
dc.description.sourcetitleHPB Surgery
dc.description.volume2016
dc.description.page6120143
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1155_2016_6120143.pdf1.37 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons